TAK logo

TAK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-11.43%
TAK Quarterly EBITDA YoY % (7.90% → -11.43%)
High-resolution chart · PNG

TAK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) EBITDA Growth — Quarterly
Period endingEBITDA Growth
-11.4288%
-14.5591%
134.5917%
-22.0849%
13.1035%
-47.1174%
-24.9076%
162.7354%
6.12%
71.7891%
-29.3461%
-49.424%
-0.8439%
51.8435%
36.6672%
18.3683%
-15.508%
-32.562%
-5.9069%
29.1182%
37.1073%
260.7042%
32.5631%
-3.2405%
86.0706%
-36.0161%
97.2228%
67.6351%
16.3518%
480.9285%
-21.1435%
47.0482%
-42.068%
-176.635%
35.3419%
6.6801%
29.1701%
-141.5409%
-5.6068%
-31.1841%
99.6995%
107.7989%
-34.9342%
3.8486%
-11.579%
-398.579%
24.9786%
-12.4595%
12.4538%
449.4146%
53.9262%
13.5585%
29.4951%
104.1945%
-59.3364%
-47.9255%
-65.3956%
-43.0137%
-12.9955%
-21.2307%
-8.1043%
4.5272%
-3.8776%
-5.4751%
-14.1011%
-1.5141%
-15.4119%
7.9021%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.